News Roundup [abridged Versions Appear In The Paper Journal]

Drug companies succeed in keeping payments to doctors secret

BMJ 2003; 327 doi: http://dx.doi.org/10.1136/bmj.327.7426.1248-a (Published 27 November 2003) Cite this as: BMJ 2003;327:1248
  1. Bob Burton
  1. Canberra

    Lobbying by Australia's drug industry association, Medicines Australia, has persuaded the Australian Competition and Consumer Commission (ACCC) to scrap a proposal to require public disclosure of drug companies' sponsorship of doctors' travel and accommodation and other promotional benefits.

    The commission, a government agency established to protect consumers from anticompetitive activity, had originally proposed accrediting a self regulatory code on the marketing of drugs developed by Medicines Australia member companies, subject to certain amendments.

    The first amendment laid down that Medicines Australia publish details of all breaches of the code on its website in full and …

    Sign in

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe